Screen high risk people for hepatitis B: USPSTF
Screen high risk people for hepatitis B: USPSTF
By Megan Brooks
NEW YORK (Reuters Health) - The U.S. Preventive Services
Task Force (USPSTF) has issued updated recommendations on
screening for hepatitis B virus (HBV) infection.
After reviewing the latest evidence, the Task Force now
recommends screening people who have the following risk factors
for HBV infection:
* People born in countries and regions with a high
prevalence of HBV infection, such as Africa, Southeast Asia,
Pacific Islands, China, Middle East, Eastern Europe, and the
northern countries in South America.
* U. S.-born persons not vaccinated as infants whose
parents were born in countries or regions with a high prevalence
of HBV infection.
* HIV-positive people, injection drug users, men who
have sex with men, and those living with or having sex with
someone with HBV infection.
* Patients with weakened immune systems or undergoing
treatment for kidney failure (hemodialysis).
What's changed since the 2004 USPSTF recommendation on
hepatitis B screening?
Task force member Dr. Douglas K. Owens, professor of
medicine and of health research and policy at Stanford
University in California, explained, "In 2004, the USPSTF
recommended against screening in the general population for
chronic HBV infection (D Recommendation). An accurate screening
test, advances in treatment and health outcomes, and effective
antiviral therapies with small harms led the Task Force to
update its recommendation and recommend HBV infection screening
for high-risk individuals (B recommendation)."
"The main difference between the 2004 and this new
recommendation is that this recommendation does not include a
recommendation for the general population, and instead focuses
on high-risk populations. The prevalence of HBV infection is low
in the general U.S. population," Dr. Owens said by email.
Up to 2.2 million people in the U.S. are chronically
infected with hepatitis B and 15% to 25% of those people die
from liver disease or liver cancer, the task force notes in a
statement.
"Screening can identify people who have chronic HBV
infection, and the good news is that treatment can help prevent
liver cancer in these people," Dr. Owens said.
The USPSTF, he added, "aims to keep all recommendations
current and review each topic every five years. The Task Force
is involved in the development of recommendations for a
significant number of topics, and occasionally urgent topics
(such as those that pose a greater risk to public health) emerge
and must be prioritized. Some recommendations also take longer
than others to develop and finalize for several reasons, such as
the scope and complexity of the issue, the time needed for
additional consideration of public and partner feedback, or
other external factors such as the publication schedules of
journals."
The updated recommendation on hepatitis B screening is
available online now in the Annals of Internal Medicine and on
the USPSTF web site at: www.uspreventiveservicestaskforce.org.
SOURCE: http://bit.ly/1iwcCpe
Ann Intern Med 2014.
|